Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-08-19
1993-04-13
Chan, Y. Christina
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530317, 530323, 530332, A61K 3702, C07K 754
Patent
active
052023095
ABSTRACT:
An antibiotic agent produced by the cultivation of Zalerion arboricola which is a cyclic lipopeptide with very high activity against human pathogens and of very low mammalian toxicity is described. Its production and isolation are also described.
REFERENCES:
patent: 3978210 (1976-08-01), Mizuno et al.
patent: 4024245 (1977-05-01), Hoehn et al.
patent: 4024246 (1977-05-01), Higgens et al.
patent: 4173629 (1979-11-01), Dreyfuss et al.
patent: 4287120 (1981-09-01), Abbott et al.
patent: 4288549 (1981-09-01), Boeck et al.
patent: 4293482 (1981-10-01), Abbott et al.
patent: 4293483 (1981-10-01), Debono
patent: 4293485 (1981-10-01), Debono
patent: 4293487 (1981-10-01), Debono
patent: 4293488 (1981-10-01), Debono
patent: 4293489 (1981-10-01), Debono
patent: 4293490 (1981-10-01), Abbott et al.
patent: 4293491 (1981-10-01), Debono
patent: 4299762 (1981-11-01), Abbott et al.
patent: 4299763 (1981-11-01), Abbott et al.
patent: 4304716 (1981-12-01), Abbott et al.
patent: 4320053 (1982-03-01), Abbott et al.
patent: 4320054 (1982-03-01), Abbott et al.
patent: 4322338 (1982-03-01), Abbott et al.
patent: 4737487 (1988-04-01), Watts et al.
patent: 4931352 (1990-06-01), Fromtling et al.
Hague et al., A.J.C.P. vol. 87, No. 4, pp. 504-510 (Apr. 1987).
Edman et al., Nature, vol. 334, pp. 519-522 (Aug. 11, 1988).
Robson et al., Introduction to Proteins and Protein Engineering, Elsevier, N.Y. pp. 323-325 (1986).
Cram et al., Organic Chemistry, 2nd Edition, McGraw-Hill Book Company, pp. 607-613 (1964).
Kurokawa et al., J. Am. Chem. Soc. vol. 108, pp. 6041-6043 (1986).
Schwartz, et al., J. Antibiotics, XLII, No. 2, 163 (1989).
Wichmann et al., J. Antibiotics, XLII, No. 2, 168 (1989).
Fromtling et al., J. Antibiotics, XLII, No. 2, 174 (1989).
Benz et al., Helv. Chim. Acta 57, 8, 2459-77 (1974).
Traber et al., Helv. Chim. Acta 62, 4, 1252-67 (1979).
Roy et al., J. Antibiotics, XL, 3, 275-80 (1987).
Mukhopadhyay et al., J. Antibiotics, XL, 3, 281-89 (1987).
Gordee et al., J. Antibiotics XXXVII, 9, 1054-65 (1984).
Debono, M. et al., Annals N.Y. Acad. Sci., 152, (1988).
Debono, M. et al., J. Antibiotics 42, No. 3, 389 (1989).
Pache, W. et al., 13th International Congress Chemotherapy (1983), PS4, 8/3, Part 115, Abstract No. 10; also referenced in Ann. Reports in Med. Chem. 19, Sec. III, 130-131.
CRC Handbook of Antibiotic Compound, vol. IV, Part I pp. 355-367.
Hughes, W. T., Index Medicus, 90: 5850 (Abstract of Eur. J. Epidemiol. (Sep. 1989), vol. 5 (3) pp. 265-269).
Hensens Otto D.
Joshua Henry
Liesch Jerrold M.
Schmatz Dennis M.
Schwartz Robert E.
Chan Y. Christina
Merck & Co. , Inc.
Robertson Alice O.
Speer Raymond M.
LandOfFree
Antibiotic cyclopeptide fermentation product does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibiotic cyclopeptide fermentation product, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibiotic cyclopeptide fermentation product will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1155416